Eurogentec joins MabDesign
Eurogentec is pleased to announce its membership in MabDesign, a leading European network dedicated to biotherapies and bioproduction.
MabDesign brings together more than 200 companies and experts across the entire biotherapy workflow, from R&D to bioproduction, with the goal of fostering innovation and collaboration within the sector.
What does this bring to Eurogentec?
Joining MabDesign gives Eurogentec access to new opportunities including:
- New collaboration and business development opportunities
- Participation in scientific events, conferences and B2B meetings
- Access to specialized training and industry expertise
What does this mean for our customers and partners?
Being part of MabDesign strengthens Eurogentec’s connection with the broader biotherapy ecosystem.
This collaboration will support our ability to:
- anticipate evolving industry needs and expectations
- continue developing innovative solutions aligned with current and future market trends
- strengthen our expertise through increased interaction with key players across the sector
- support innovation-driven projects preparing the therapies of tomorrow
By remaining closely connected to the evolution of the biotherapy landscape, Eurogentec continues its commitment to delivering high-quality, forward-looking solutions to its customers and partners.
Together, let’s open new perspectives in biotherapy.
